Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Zumla A, Hui DS, Azhar EI, Memish ZA, et al. Lancet 2020 Feb 5. pii: S0140-6736(20)30305.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zumla A, Hui DS, Azhar EI, Memish ZA, et al. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet 2020 Feb 5. pii: S0140-6736(20)30305.
PMID: 32035018